V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240000082 | 240000082 | null | null | null | null | 2016-12-17 | null | null | null | DA | 101798907 |
| 240000085 | 240000085 | 1.85 | 84.95 | 03 | 2019-01-15 | 2019-01-20 | AML 18 TRIAL | 02 | N | AML19 TRIAL | 100160350 |
| 240000088 | 240000088 | 1.72 | 55.5 | 03 | 2019-12-11 | 2019-12-11 | CHOP - 21 days | 01 | Y | CYTARABINE + DAUNORUBICIN + GEMTUZUMAB OZOGAMICIN | 100531689 |
| 240000097 | 240000097 | 1.72 | null | Adjuvant (A) | 2018-05-04 | 2018-05-08 | CHOP R - 21 days | N | N | CHOP R | 100387520 |
| 240000100 | 240000100 | 1.57 | 82.3 | Curative (C) | null | 2017-11-27 | null | 02 | N | HYDROXYCARBAMIDE | 101495238 |
| 240000112 | 240000112 | null | null | null | null | 2017-04-30 | ANAGRELIDE | null | null | RUXOLITINIB | 100937283 |
| 240000125 | 240000125 | 1.84 | 65.9 | Curative (C) | 2018-09-11 | 2018-09-12 | null | 2 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100685136 |
| 240000130 | 240000130 | null | null | null | null | 2017-11-17 | null | null | null | DA | 101107919 |
| 240000134 | 240000134 | 1.37 | 80 | Curative (C) | null | 2019-04-25 | AML 19 TRIAL | N | N | TRIAL UNSPECIFIED | 100253490 |
| 240000139 | 240000139 | null | null | null | null | 2018-06-04 | Methotrexate intrathecal | null | null | TRIAL | 101753191 |
| 240000147 | 240000147 | 1.65 | 69 | Curative (C) | 2017-06-20 | 2017-06-20 | Hydroxycarbamide | 02 | N | CYTARABINE + DAUNORUBICIN | 100339028 |
| 240000154 | 240000154 | 1.51 | 16.2 | Palliative (P) | 2018-12-22 | 2018-12-22 | Hydroxycarbamide | 01 | N | CHOP R | 101496903 |
| 240000165 | 240000165 | 1.88 | 88.85 | 03 | null | 2019-08-08 | CLADRIBINE | 02 | N | METHOTREXATE | 100762207 |
| 240000175 | 240000175 | null | null | null | null | 2016-03-22 | CYTARABINE + DAUNORUBICIN + Gemtuzumab Ozogamicin | null | null | AML19 TRIAL | 101413705 |
| 240000176 | 240000176 | null | null | null | null | 2016-07-28 | CHOP R | null | null | AML18 TRIAL | 100608289 |
| 240000181 | 240000181 | 1.6 | 92 | Palliative (P) | null | 2018-11-24 | null | N | N | DA | 100757647 |
| 240000183 | 240000183 | 0 | 67.45 | Curative (C) | 2016-07-21 | 2016-08-01 | null | 02 | N | AZACITIDINE | 101355904 |
| 240000184 | 240000184 | null | null | null | null | 2019-06-14 | null | null | null | RITUXIMAB | 100481074 |
| 240000187 | 240000187 | 1.69 | 46 | Disease modification (D) | null | 2017-11-25 | CHOP R | 02 | N | METHOTREXATE | 100122908 |
| 240000191 | 240000191 | null | null | null | null | 2017-02-13 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101647155 |
| 240000194 | 240000194 | 1.5 | null | Curative (C) | 2015-10-31 | 2015-10-31 | null | 01 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101466370 |
| 240000202 | 240000202 | null | null | null | null | 2019-09-02 | null | null | null | AML19 TRIAL | 101517298 |
| 240000208 | 240000208 | 1.81 | 62 | 03 | null | 2017-08-12 | null | Y | null | DOXORUBICIN | 101698847 |
| 240000209 | 240000209 | 1.67 | 64 | Curative (C) | null | 2017-04-18 | null | 02 | N | CYTARABINE + DAUNORUBICIN | 100232590 |
| 240000212 | 240000212 | null | null | null | null | 2019-02-12 | null | null | null | IMATINIB | 100463901 |
| 240000227 | 240000227 | null | null | null | null | 2018-03-07 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101579810 |
| 240000228 | 240000228 | null | null | null | null | 2016-04-28 | null | null | null | AML MYECHILD 01 A MITOZANTRONE/CYTARABINE + GO | 101856411 |
| 240000240 | 240000240 | 1.54 | 60.8 | Palliative (P) | null | 2012-08-27 | CHOP R | 01 | N | DA | 100040696 |
| 240000246 | 240000246 | 1.67 | null | 03 | null | 2016-10-27 | CHOP R | 02 | N | CYTARABINE + DAUNORUBICIN | 100354396 |
| 240000249 | 240000249 | 1.77 | 85.7 | Adjuvant (A) | 2019-11-06 | 2019-11-09 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | Y | AML MYECHILD 01 IT CYT | 101594645 |
| 240000250 | 240000250 | 1.67 | 87.3 | 03 | 2016-08-20 | 2016-08-20 | null | N | N | DA | 100208907 |
| 240000251 | 240000251 | 0.81 | 67.4 | Curative (C) | 2018-07-12 | 2018-07-12 | null | 02 | N | CYTARABINE | 100426765 |
| 240000252 | 240000252 | 1.6 | 76.5 | Curative (C) | 2017-11-30 | 2017-11-30 | null | 02 | N | FLAG + IDARUBICIN | 100501482 |
| 240000258 | 240000258 | 1.62 | 72 | 03 | null | 2016-10-31 | Hydroxycarbamide | N | N | CYTARABINE | 101375977 |
| 240000265 | 240000265 | 1.65 | 72.1 | Curative (C) | null | 2017-07-17 | null | 02 | N | CHOP R | 100740284 |
| 240000266 | 240000266 | 1.77 | 79.1 | Curative (C) | null | 2019-03-26 | null | 02 | N | CYTARABINE + DAUNORUBICIN + GEMTUZUMAB OZOGAMICIN | 101107080 |
| 240000267 | 240000267 | 1.72 | 79.2 | Curative (C) | null | 2016-01-30 | Azacitidine | 02 | N | AML19 TRIAL | 101535796 |
| 240000269 | 240000269 | 1.6 | 71.8 | Adjuvant (A) | 2019-07-23 | 2019-07-26 | null | 2 | N | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 100118060 |
| 240000272 | 240000272 | 1.7 | 98 | Curative (C) | null | 2019-03-12 | null | 02 | N | AML19 TRIAL | 101862492 |
| 240000276 | 240000276 | 0 | 69.5 | Curative (C) | null | 2016-05-20 | Idarubicin+Tretinoin Spanish Crse1 | 02 | N | BORTEZOMIB + THALIDOMIDE | 101343010 |
| 240000280 | 240000280 | null | null | null | null | 2017-08-19 | null | null | null | CHLORAMBUCIL + OBINUTUZUMAB | 100360472 |
| 240000284 | 240000284 | 1.76 | 71.95 | Curative (C) | null | 2016-06-26 | AML 19 TRIAL | 01 | N | CHOP | 101832953 |
| 240000290 | 240000290 | 1.64 | 57.2 | 03 | null | 2019-11-13 | AML 18 TRIAL | 02 | N | AML18 TRIAL | 100574666 |
| 240000292 | 240000292 | 1.82 | 102.9 | Curative (C) | null | 2017-01-24 | CHLORAMBUCIL + OBINUTUZUMAB | null | N | HYDROXYCARBAMIDE | 101232506 |
| 240000294 | 240000294 | 1.66 | null | 03 | null | 2018-08-14 | null | 02 | N | AML18 TRIAL | 101862268 |
| 240000295 | 240000295 | 1.64 | 80 | Curative (C) | null | 2017-11-24 | AML 19 TRIAL | null | N | BENDAMUSTINE + RITUXIMAB | 100268079 |
| 240000296 | 240000296 | 1.7 | 70 | Palliative (P) | null | 2016-04-13 | AML 18 TRIAL | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100886668 |
| 240000297 | 240000297 | 1.69 | 59 | Palliative (P) | 2016-12-07 | 2016-12-08 | CHOP R - 21 days | N | N | CYTARABINE + DAUNORUBICIN | 100525706 |
| 240000301 | 240000301 | null | null | null | 2017-03-07 | 2017-03-18 | CYTARABINE + DAUNORUBICIN | 02 | null | CYTARABINE | 100430324 |
| 240000304 | 240000304 | 1.78 | 62.1 | 03 | null | 2016-09-26 | null | 02 | N | LCHIV IC-1 | 101690208 |